|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/06 | (2006.01) |
| A61K 31/4439 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 2125779 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07857408.4 |
| Date of filing the European patent application | 2007-12-11 | |
| (97) | Date of publication of the European application | 2009-12-02 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-27 |
| (46) | Date of publication of the claims translation | 2016-07-11 |
| (86) | Number | PCT/EP2007/063721 |
| Date | 2007-12-11 |
| (87) | Number | WO 2008/074697 |
| Date | 2008-06-26 |
| (30) | Number | Date | Country code |
| 876398 P | 2006-12-21 | US |
| (72) |
CLEARY, Thomas P., US
GLOMME, Alexander, CH
GRASSMANN, Olaf, DE
KUANG, Shan-Ming, US
MEIER, Roland, CH
MILLER, Doreen, US
MOOG, Regina, DE
ROHRER, Franziska E., CH
YANG, Jason, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstra e 124, 4070 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | MGLUR5 receptoriaus antagonisto polimorfai |
| POLYMORPHS OF A MGLUR5 RECEPTOR ANTAGONIST |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 18 | 347.00 EUR |
| 2025-12-11 |